A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults
Clinical trial NCT04591184 · COMPLETED
Trial details
- NCT number
- NCT04591184
- Sponsor
- Entos Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-07
- Primary completion
- 2023-12-06
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.